What is the name of your organization?
Briota Technologies Pvt Ltd
What is the name of your solution?
SURAKSHA™ by Briota Technologies
Provide a one-line summary or tagline for your solution.
Briota SURAKSHA™ is an AI-enabled point-of-care platform that delivers rapid, integrated 14-biomarker NCD screening with real-time risk stratification in a single visit.
In what city, town, or region is your solution team headquartered?
Pune
In what country is your solution team headquartered?
—
What type of organization is your solution team?
For-Profit
Film your elevator pitch.
—
What specific problem are you solving?
Non-communicable diseases (NCDs) cause most global deaths, yet early screening remains inaccessible and fragmented. Patients must undergo multiple costly tests, often resulting in delayed diagnosis and advanced complications. Limited primary care infrastructure further restricts preventive care. Affordable, integrated, point-of-care screening is urgently needed to enable early risk detection and intervention.
What is your solution?
Briota SURAKSHA™ is an AI-enabled point-of-care testing (POCT) platform designed to deliver comprehensive screening for 14 non-communicable disease (NCD) biomarkers in a single visit. The portable system integrates multi-analyte diagnostics with automated, cloud-connected AI risk stratification to assess cardiometabolic, renal, and related chronic disease risks within minutes. By consolidating multiple laboratory tests into one streamlined workflow, SURAKSHA™ reduces cost, time, and infrastructure requirements, making preventive screening feasible in primary care clinics, community health settings, workplaces, and outreach programs. The platform generates instant digital reports with actionable risk insights, enabling providers to initiate early lifestyle, medical, or referral interventions. Its interoperable data architecture supports population-level analytics while maintaining patient privacy. Designed for use by trained frontline providers rather than specialists, SURAKSHA™ democratizes access to advanced diagnostics and shifts NCD detection from centralized laboratories to decentralized community-based care environments.
Who does your solution serve, and in what ways will the solution impact their lives?
SURAKSHA™ enables a systemic shift from late-stage disease management to early risk identification and prevention. By detecting NCD risks before symptoms escalate, the platform reduces preventable complications such as heart attacks, kidney failure, COPD, and diabetes-related morbidity. Early identification supports timely clinical intervention, improving long-term outcomes and lowering hospitalization rates and catastrophic health expenditures. For health systems, consolidated screening improves efficiency, reduces diagnostic fragmentation, and generates real-time population risk insights to guide targeted interventions and policy planning. Employers and insurers benefit from healthier populations and reduced productivity losses linked to chronic disease. At the community level, SURAKSHA™ expands equitable access to high-quality preventive screening, particularly for populations with limited laboratory access. Over time, widespread deployment can reduce national NCD burden, ease pressure on tertiary care facilities, and create sustainable, prevention-focused healthcare ecosystems grounded in data-driven decision-making.
